Markus Loeffler
Hoofd Techniek/Wetenschap/O&O bij NH THERAGUIX SAS
Profiel
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Actieve functies van Markus Loeffler
| Bedrijven | Functie | Begin |
|---|---|---|
| NH THERAGUIX SAS | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Opleiding van Markus Loeffler
| INSEAD | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
